AI assistant
Sending…
CAMBRIDGE NUTRITIONAL SCIENCES PLC — Major Shareholding Notification 2014
Mar 4, 2014
7544_rns_2014-03-04_4db4d04a-e451-42c2-bf5d-f1d559d4a749.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5082B
Omega Diagnostics Group PLC
04 March 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Omega Diagnostics | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | x | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Killik & Co LLP | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | Platform Securities (on behalf of various discretionary clients of Killik & Co LLP) |
||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
3rd March 2014 | ||||
| 6. Date on which issuer notified: | 4th March 2014 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
Under 3% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Omega Diagnostics | 3,597,352 | 3,597,352 | 3,236,517 | 3,236,517 | Under 3% | |||||||||||
| GB00B1VCP282 | ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 3,236,517 | Under 3% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Heidi Richer | |
| 15. Contact telephone number: | 020 7337 0400 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSRVRSVAORAR
More from CAMBRIDGE NUTRITIONAL SCIENCES PLC
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 31
Major Shareholding Notification
2026
Mar 31
Director's Dealing
2025
Nov 19
Interim / Quarterly Report
2025
Nov 10
Report Publication Announcement
2025
Nov 4
Declaration of Voting Results & Voting Rights Announcements
2025
Sep 25
Report Publication Announcement
2025
Aug 28
Remuneration Information
2025
Aug 21
Annual Report
2025
Aug 19